Cal Poly student startup sold
A San Luis Obispo startup founded by Cal Poly students has been acquired by a Silicon Valley firm, marking the second sale of a student business from the school in two years. Quest.to, which was founded during a Startup Weekend event in 2012 and then attended the HotHouse summer accelerator program organized by the school’s Read More →
Read More →Asta Fluidic takes top spot at UCSB competition
A UC Santa Barbara team developing a cheap and easy technology to test for a serious pregnancy complication is the winner of the school’s 14th annual New Venture Competition. Asta Fluidic Technologies is developing a chip that could drastically reduce the time and cost of testing for fetomaternal hemorrhage, a condition in which the red Read More →
Read More →
Shopping for shipping: ShipHawk aims to make sending stuff easier
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Don’t mind the gap: Ventura firm’s lightweight motors well-suited to electric cars, drones
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Yardi Systems looks to double sales in three years as it expands into new software niches
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Amgen teams up for Chinese joint venture
Thousand Oaks-based biotech giant Amgen has teamed up with a Chinese company for a joint venture to sell its colorectal cancer drug Vectibix there. Zhejiang Beta Pharma will be 51 percent owner of the the new firm, which will be known as Amgen-Beta Pharmaceuticals. The deal is still subject to approval from Chinese authorities. Amgen’s Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
